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A B S T R A C T
Blue light can damage retina and cause age related macular degeneration. After cataract surgery and lens removal
retina stays unprotected. Blue light filtering intraocular lenses (IOL) increase protection of the retina. In our prospective
study we investigated clinical results after billateral implantation of Acrysof Natural IOL to 30 patients (N=60 eyes). In
a control group (N=60 eyes, 30 patients), standard acrysof IOL was implanted bilaterally. Uncorrected visual acuity
(UCVA), best corrected visual acuity (BCVA) and Nd YAG laser capsulotomy rate were measured and compared with con-
trol group. Subjective patient's satisfaction and subjective colour perception were also investigated. There was no signifi-
cant difference in UCVA, BCVA and Nd YAG laser capsulotomy rate between the two groups. High patient's satisfaction
was noticed (96,7% of patients would implant Acrysof Natural IOL again). Acrysof Natural IOL enables good visual
acuity VA, low rate of Nd YAG laser capsulotomy and high patient's satisfaction without colour perception disturbances.
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Introduction
The blue light region in the visible light spectrum is
between 400–500 nm. It has the highest amount of en-
ergy in this spectrum and potentially can cause the larg-
est damage on the retina1–2. Blue light is a component of
sunlight and some artificial light sources such as office
light, computers etc. Naturally human eye has its own
protection against blue light in cornea, lens and macula
(which contents yellow pigment). Those are natural blue
light filters and lens is a major one. As we age, retina
loses ability to produce yellow pigment and stays unpro-
tected. But at the same time lens becomes more and
more yellow and compensate loss of the macular pig-
ment3. The problem exists when we do the cataract sur-
gery or clear lens extraction and remove the only protec-
tion that has left in the eye (namely, cornea has only sym-
bolic role in blue light filtering)4. After cataract removal
blue light can freely reach retina. In the aging eye, retina
becomes built up of the lipofuscin. A major constituent of
lipofuscin is the fluorescent pigment A2E5. It accumu-
lates in retinal pigment epithelium cells6. Excited by the
blue light A2E creates free radicals and causes RPE cells
death that leads to age related macular degeneration
(AMD)7. There are experiments that showed that blue
light illumination of the RPE cell culture models accu-
mulated with lipofuscin fluorophore A2E causes RPE
cells apoptosis7. This is a link between blue light, cata-
ract surgery and AMD. Cataract surgery significantly in-
creases the risk for AMD4. Standard intraocular lenses
protects only against UV light. Blue light filtering intra-
ocular lens (Acrysof Natural IOL) contains covalently
bounded cromophore that filters blue light and increases
protection of the retina. It also absorbs UV light. Blue
light filtering intraocular lens (Acrysof Natural IOL)
transmits blue light similar to a fifty-three years old
crystalline lens8. Studies have shown there are no detri-
mental effects on colour vision, contrast sensitivity and
visual acuity after Acrysof Natural IOL implantation9–10.
In our study we investigated clinical effects of Acrysof
Natural implantation.
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Patients and methods
This was a prospective, randomized comparative stu-
dy. Patients were divided in two groups. First one in-
cluded 30 patients (60 eyes) where blue light filtering
intraocular lens (Acrysof Natural IOL) was bilaterally
implanted. Control group included 30 patients, (60 eyes)
with conventional AcrySof MA60BM IOL implantation.
There were no significant differences between the two
investigated groups regarding age, gender and ocular pa-
thology. Mean age in »Natural group« was 68±4.5 years
and 67±4.2 years in control group. In both groups we
had 21 females and 9 males. Patients with glaucoma, ret-
inal, or any other severe ocular pathology were excluded
from the study. Cataract extraction was performed by
PHACO surgery in the Eye Clinic »Svjetlost« (Infiniti,
Alcon Laboratories Inc.) and University Department of
Ophthalmology of General Hospital »Sveti Duh« (Legacy,
Alcon Laboratories Inc.) in Zagreb, Croatia by two sur-
geons. There were no intraoperative or postoperative
complications. Follow up was 6 months. Uncorrected vi-
sual acuity, best corrected visual acuity and Nd YAG la-
ser capsulotomy rate were measured and compared in
both groups. Patients were asked about their subjective
satisfaction and subjective colour perception under pho-
topic and mesopic conditions. In six patients AcrySof
Natural IOL was implanted in one eye and AcrySof
MA60BM IOL in other eye. We compared patient's satis-
faction and subjective color perception under photopic
and mesopic conditions between the two eyes. SPSS 11.0
for Windows was used for statistical analysis. Since there
were two investigated groups with dichotomous vari-
ables, statistical significance was determined by Chi-
Square test at level of 5%.
Results
Patients achieved similar uncorrected visual acuity
(UCVA) in both groups. UCVA better than 0.8 (20/25)
was achieved in 86.7% patients in »Natural group« and
in 85.0% of those in control group) (Figure 1). There was
no statistically significant difference between groups
(Chi-square=0.69; df=1; p=0.793) (Figure 2). All pa-
tients regardless of the type of implanted IOL, achieved
BCVA better than 0.8 (20/25) (Figure 3). Nd YAG laser
capsulotomy rate was low (Figure 4) and there was no
statistically significant difference between two groups
(Chi-square=0.152; df=1; p=0.5), (Figure 5). High pa-
tient's satisfaction was noticed since 96, 66 % of patients
would implant AcrySof Natural IOL again (Figure 6).
Only one patient would not implant this lens again due
to the fact that other people can see yellow »shine« in his
eye. None of the patients reported any colour perception
disturbances in photopic or mesopic conditions. Out of 6
patients having AcrySof Natural IOL in one and stan-
dard AcrySof IOL in other eye, 3 patients were more sat-
isfied with AcrySof Natural IOL, 2 of them didn't notice
any difference and one of them was more satisfied with
AcrySof MA60BM IOL. There was no difference in color
perception under photopic and mesopic conditions be-
tween the two eyes.





















Fig. 1. Uncorrected visual acuity (UCVA) at six postoperative
months on patients implanted with blue light filtering lens (Acry-
























Fig. 2. Statistical analysis of difference between uncorrected vi-






















Fig. 3. Best corrected visual acuity (BCVA) at six postoperative
month on patients implanted with blue light filtering lens (Acry-


















Fig. 4. Nd YAG laser capsulotomy rate in eyes implanted with
blue light filtering lens (Acrysof Natural IOL) and standard
acrylic lens (Acrysof MA60BM) at six postoperative months.
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Disscusion
According to our data, AcrySof Natural IOL enables
good visual acuity which is comparable to results with
standard acrysof lenses. The rate of Nd YAG laser cap-
sulotomy is low in both investigated groups. Patients had
to fill the questioner about colour perception distur-
bances in conditions of bright and low light. There were
some critics of this lens stating that blue light filtering
reduces ability to discriminate between dark blue and
black colours, especially in low light conditions11. Our
study have shown that there are no subjective colour per-
ception disturbances. The study conducted by Robert J.
Cionni also showed there is no difference in colour per-
ception between patients with Acrysof Natural IOL and
those with Acrysof SA60AT IOL and phakic patients12.
In the group where Acrysof Natural IOL was implanted
in one eye and standard Acrysof IOL in the fellow eye few
patients state that they prefer one type of the lens over
other. However, they could not give us some specific rea-
sons why they prefer one or the other lens. We can as-
sume they would not report any difference if they had
not been specifically asked for that. Patients were in-
formed that different lenses were implanted. None of
them had noticed any difference in colour perception be-
tween the two eyes. The aim of this study was not to in-
vestigate whether Acrysof Natural IOL prevent or re-
duce risk of age related macular degeneration since fol-
low up was much to short for such conclusions. Our goal
was to check clinical effects after its implantation and to
investigate eventual detrimental effects on visual acuity
and subjective colour perception. Evidences suggest that
blue light can damage macula in patients who underwent
cataract surgery or clear lens extraction6,13. Also it is
shown that RPE cells accumulated with lipofuscin and
exposed to blue light undergo apoptosis. However, when
we put Acrysof Natural IOL between blue light source
and RPE cell culture model, cells stay viable14. AMD is a
leading cause of central vision loss among people over 50
years of age in developed world. Some believe that AMD
is related to genetics, while others thinks that environ-
mental factors such as smoking, light and diet cause
AMD. Since we are not satisfied with AMD tratments, we
should try to prevent the disease. Blue light is surely not
the only risk factor for AMD, but we can assume that
blue light filtering IOLs may reduce risk of this disease.
However, for such conclusion a longer follow up of pa-
tients implanted with Acrysof Natural IOL is needed.
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Fig. 5. Statistical analysis of difference between Nd YAG laser
capsulotomy rate after AcrySof Natural IOL and AcrySof MA60
BM IOL implantation.
Fig. 6. Patient's subjective satisfaction after Acrysof Natural IOL
and Acrysof MA60BM IOL implantation.
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INTRAOKULARNE LE]E S FILTEROM PLAVOG SVJETLA U ULTRAZVU^NOJ
OPERACIJI KATARAKTE
S A @ E T A K
Plavo svjetlo mo`e o{tetiti mre`nicu i uzrokovati senilnu degeneraciju makule. Nakon operacije mrene i odstra-
njenja le}e mre`nica ostaje neza{ti}ena. Intraokularne le}e (IOL) s filterom plavog svjetla pove}avaju za{titu mre`nice.
U na{oj prospektivnoj studiji ispitivali smo klini~ke rezultate nakon obostrane ugradnje Acrysof Natural IOL kod 30
bolesnika (N=60 o~iju). U kontrolnoj skupini (30 bolesnika, N=60 o~iju) ugradili smo obostrano standardnu, akrili~nu
IOL. Mjerili smo nekorigiranu vidnu o{trinu (UCVA), najbolje korigiranu vidnu o{trinu (BCVA) i u~estalost Nd YAG la-
ser kapsulotomije i usporedili s kontrolnom skupinom. Ispitivali smo i subjektivno zadovoljstvo i osjet boja bolesnika.
Nije na|ena zna~ajna razlika u UCVA, BCVA i u~estalosti Nd YAG kapsulotomije izme|u dvije skupine. Bolesnici su bili
izrazito zadovoljni (96,7% bolesnika bi ponovno ugradili Acrysof Natural IOL). Acrysof Natural IOL omogu}ava dobru
vidnu o{trinu, nisku u~estalost Nd YAG laser kapsulotomije i visoko zadovoljstvo bolesnika bez smetnji osjeta boja.
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